A synthetic route to an anti-cancer drug, lapatinib, was devised to support the development of a sustainable manufacturing process in South Africa. Quantitative metrics were employed to evaluate the sustainability of the key steps of the reaction.The ROAR facility by EPSRC.https://pubs.rsc.org/en/journals/journalissues/ream2023Chemistr
My PhD research project has been finalized to the discovery of potential RAD51-BRCA2 protein-protein...
This paper presents a summary of the evidencereview group (ERG) report into the clinicaleffectivenes...
Includes bibliographical references (p. ).Cancer is the second leading cause of death in the United ...
A synthetic route to an anti-cancer drug, lapatinib, was devised to support the development of a sus...
Lapatinib is a small molecule, a heterocyclic quinazoline derivative. The drug is used for targeted ...
Over the last few decades organic chemists have developed highly sophisticated chemical reactions to...
Background: Sulindac belongs to the chemically diverse family of Non-Steroidal Anti-Inflammatory Dru...
Harnessing the power of process intensification principles in a robust synthesis of the anti-retrovi...
Includes bibliographical references.Natural products have been exploited by humans as the most consi...
The new technology of combinational chemistry has been introduced to pharmaceutical companies, impro...
Imatinib is one of the first cancer therapies that has shown a potential for a novel approachin canc...
Lapatinib, an approved epidermal growth factor receptor inhibitor, was explored as a starting point ...
Identification of bioactive compounds from natural sources represents only the first stage in the de...
Nilotinib (Tasigna) is a drug used to treat chronic myelogenous leukemia (CML), a disease which curr...
Brendan Corkery1,2, Norma O’Donovan2, John Crown1,21St. Vincent’s University Hos...
My PhD research project has been finalized to the discovery of potential RAD51-BRCA2 protein-protein...
This paper presents a summary of the evidencereview group (ERG) report into the clinicaleffectivenes...
Includes bibliographical references (p. ).Cancer is the second leading cause of death in the United ...
A synthetic route to an anti-cancer drug, lapatinib, was devised to support the development of a sus...
Lapatinib is a small molecule, a heterocyclic quinazoline derivative. The drug is used for targeted ...
Over the last few decades organic chemists have developed highly sophisticated chemical reactions to...
Background: Sulindac belongs to the chemically diverse family of Non-Steroidal Anti-Inflammatory Dru...
Harnessing the power of process intensification principles in a robust synthesis of the anti-retrovi...
Includes bibliographical references.Natural products have been exploited by humans as the most consi...
The new technology of combinational chemistry has been introduced to pharmaceutical companies, impro...
Imatinib is one of the first cancer therapies that has shown a potential for a novel approachin canc...
Lapatinib, an approved epidermal growth factor receptor inhibitor, was explored as a starting point ...
Identification of bioactive compounds from natural sources represents only the first stage in the de...
Nilotinib (Tasigna) is a drug used to treat chronic myelogenous leukemia (CML), a disease which curr...
Brendan Corkery1,2, Norma O’Donovan2, John Crown1,21St. Vincent’s University Hos...
My PhD research project has been finalized to the discovery of potential RAD51-BRCA2 protein-protein...
This paper presents a summary of the evidencereview group (ERG) report into the clinicaleffectivenes...
Includes bibliographical references (p. ).Cancer is the second leading cause of death in the United ...